{
 "PrintNo":"A171","Session":2019,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2019-01-02T14:17:59.182006Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Consumer Affairs And Protection",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2020-01-08","Committee":"Consumer Affairs And Protection"}],
 "Actions":[
  {"Text":"REFERRED TO CONSUMER AFFAIRS AND PROTECTION","Date":"2019-01-09","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO CONSUMER AFFAIRS AND PROTECTION","Date":"2020-01-08","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":551,"Name":"Kevin Cahill","Short":"CAHILL"}],
 "Title":"Provides for the proper packaging and labeling of pharmaceutical drugs; creates penalties for intentional fraud",
 "Summary":"Provides for the proper packaging and labeling of pharmaceutical drugs; creates penalties for intentional fraudulent replacement, packaging, and labeling of such drugs; provides for better consumer protection.",
 "LawSection":"General Business Law","LawCode":"Add ยง392-k, Gen Bus L",
 "ActClause":"AN ACT to amend the general business law, in relation to preserving the integrity and safety of pharmaceutical drugs",
 "SameAsPrintNo":"S3164-2019",
 "PreviousVersions":["A29-2007","A604-2009","A320-2011","A1372-2013","A1215-2015","A101-2017"]
}